Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

A high mucosal blocking score is associated with HIV protection.

Girard A, Rallón N, Benito JM, Jospin F, Rodriguez C, Chanut B, Benjelloun F, Del Romero J, Verrier B, Lucht F, Pin JJ, Genin C, Biasin M, Clerici M, Paul S.

AIDS. 2019 Mar 1;33(3):411-423. doi: 10.1097/QAD.0000000000002099.

PMID:
30703069
2.

Limping in children: look what the cat dragged in!

Chantrain CF, Genin C.

Arch Dis Child. 2019 Jan;104(1):3-4. doi: 10.1136/archdischild-2018-315135. Epub 2018 Jun 29. No abstract available.

PMID:
29959127
3.

Neutralizing and Targeting Properties of a New Set of α4β7-Specific Antibodies Are Influenced by Their Isotype.

Girard A, Jelicic K, Van Ryk D, Rochereau N, Cicala C, Arthos J, Noailly B, Genin C, Verrier B, Laurant S, Razanajaoana-Doll D, Pin JJ, Paul S.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):118-127. doi: 10.1097/QAI.0000000000001307.

PMID:
28177967
4.

First Membrane Proximal External Region-Specific Anti-HIV1 Broadly Neutralizing Monoclonal IgA1 Presenting Short CDRH3 and Low Somatic Mutations.

Benjelloun F, Oruc Z, Thielens N, Verrier B, Champier G, Vincent N, Rochereau N, Girard A, Jospin F, Chanut B, Genin C, Cogné M, Paul S.

J Immunol. 2016 Sep 1;197(5):1979-88. doi: 10.4049/jimmunol.1600309. Epub 2016 Aug 1.

5.

Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients.

Depincé-Berger AE, Vergnon-Miszczycha D, Girard A, Frésard A, Botelho-Nevers E, Lambert C, Del Tedesco E, Genin C, Pozzetto B, Lucht F, Roblin X, Bourlet T, Paul S.

Retrovirology. 2016 Jun 30;13(1):44. doi: 10.1186/s12977-016-0278-5.

6.

Brief Report: A High Rate of β7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAART.

Girard A, Vergnon-Miszczycha D, Depincé-Berger AE, Roblin X, Lutch F, Lambert C, Rochereau N, Bourlet T, Genin C, Paul S.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):259-65. doi: 10.1097/QAI.0000000000000943.

7.

Comparison of Screening Dilution and Automated Reading for Antinuclear Antibody Detection on HEP2 Cells in the Monitoring of Connective Tissue Diseases.

Depincé-Berger AE, Moreau A, Bossy V, Genin C, Rinaudo M, Paul S.

J Clin Lab Anal. 2016 Sep;30(5):471-8. doi: 10.1002/jcla.21881. Epub 2016 May 26.

PMID:
27225012
8.

A Difficult and Rare Diagnosis of Autoimmune Enteropathy in a Patient Affected by Down Syndrome.

Depince-Berger A, Cremilieux C, Rinaudo-Gaujous M, Genin C, de Freminville B, Lambert C, Bruneau J, Paul S.

J Clin Immunol. 2016 Jul;36(5):423-8. doi: 10.1007/s10875-016-0280-7. Epub 2016 Apr 12.

PMID:
27072857
9.

Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.

Pavot V, Climent N, Rochereau N, Garcia F, Genin C, Tiraby G, Vernejoul F, Perouzel E, Lioux T, Verrier B, Paul S.

Biomaterials. 2016 Jan;75:327-339. doi: 10.1016/j.biomaterials.2015.10.034. Epub 2015 Nov 3.

PMID:
26539801
10.

[Targeting and role of α4β7 integrin in the pathophysiology of IBD and HIV infection].

Girard A, Rochereau N, Roblin X, Genin C, Paul S.

Med Sci (Paris). 2015 Oct;31(10):895-903. doi: 10.1051/medsci/20153110016. Epub 2015 Oct 19. Review. French.

11.

Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.

Rochereau N, Pavot V, Verrier B, Jospin F, Ensinas A, Genin C, Corthésy B, Paul S.

J Allergy Clin Immunol. 2016 Jan;137(1):214-222.e2. doi: 10.1016/j.jaci.2015.07.042. Epub 2015 Sep 26.

PMID:
26414879
12.

Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancer.

Iobagiu C, Lambert C, Raica M, Lima S, Khaddage A, Peoc'h M, Genin C.

Cancer Genet. 2015 Apr;208(4):135-42. doi: 10.1016/j.cancergen.2015.02.007. Epub 2015 Feb 20.

PMID:
25979597
13.

Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.

Paul S, Boschetti G, Rinaudo-Gaujous M, Moreau A, Del Tedesco E, Bonneau J, Presles E, Mounsef F, Clavel L, Genin C, Flourié B, Phelip JM, Nancey S, Roblin X.

J Crohns Colitis. 2015 Jun;9(6):445-51. doi: 10.1093/ecco-jcc/jjv063. Epub 2015 Apr 19.

PMID:
25895876
14.

Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.

Carla-Moreau A, Paul S, Roblin X, Genin C, Peyrin-Biroulet L.

Dig Liver Dis. 2015 Mar;47(3):191-6. doi: 10.1016/j.dld.2014.11.005. Epub 2014 Nov 14. Review.

PMID:
25488057
15.

Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes.

Bonneau J, Dumestre-Perard C, Rinaudo-Gaujous M, Genin C, Sparrow M, Roblin X, Paul S.

Autoimmun Rev. 2015 Mar;14(3):231-45. doi: 10.1016/j.autrev.2014.11.004. Epub 2014 Nov 13. Review.

PMID:
25462578
16.

Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells.

Rochereau N, Pavot V, Verrier B, Ensinas A, Genin C, Corthésy B, Paul S.

Eur J Immunol. 2015 Mar;45(3):773-9. doi: 10.1002/eji.201444816. Epub 2015 Jan 14.

17.

Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity.

Pavot V, Rochereau N, Rességuier J, Gutjahr A, Genin C, Tiraby G, Perouzel E, Lioux T, Vernejoul F, Verrier B, Paul S.

J Immunol. 2014 Dec 15;193(12):5781-5. doi: 10.4049/jimmunol.1402184. Epub 2014 Nov 12.

18.

Cell-free RNA content in urine as a possible molecular diagnostic tool for clear cell renal cell carcinoma.

Zhao A, Péoc'h M, Cottier M, Genin C, Mottet N, Li G.

Int J Cancer. 2015 Jun 1;136(11):2610-5. doi: 10.1002/ijc.29313. Epub 2014 Nov 28.

19.

Pharmacokinetics in IBD: ready for prime time?

Roblin X, Rinaudo M, Sparrow MP, Moreau A, Phelip JM, Genin C, Lamarque D, Paul S.

Curr Drug Targets. 2014;15(11):1049-55. Review.

PMID:
25173707
20.

Recent progress in HIV vaccines inducing mucosal immune responses.

Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S.

AIDS. 2014 Jul 31;28(12):1701-18. doi: 10.1097/QAD.0000000000000308. Review.

PMID:
25009956
21.

Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases.

Roblin X, Rinaudo M, Del Tedesco E, Phelip JM, Genin C, Peyrin-Biroulet L, Paul S.

Am J Gastroenterol. 2014 Aug;109(8):1250-6. doi: 10.1038/ajg.2014.146. Epub 2014 Jun 10.

PMID:
24913041
22.

Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis.

Paul S, Moreau AC, Del Tedesco E, Rinaudo M, Phelip JM, Genin C, Peyrin-Biroulet L, Roblin X.

Inflamm Bowel Dis. 2014 Jul;20(7):1288-95. doi: 10.1097/MIB.0000000000000037. Review.

PMID:
24831559
23.

Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis.

Moreau AC, Paul S, Del Tedesco E, Rinaudo-Gaujous M, Boukhadra N, Genin C, Peyrin-Biroulet L, Roblin X.

Inflamm Bowel Dis. 2014 Mar;20(3):464-71. doi: 10.1097/01.MIB.0000439068.71126.00.

PMID:
24418904
24.

Torsade de Pointes associated with laxative abuse in a patient receiving methadone.

Laqueille X, Genin C, Pitrat B, Lupuyau A, Dervaux A.

J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):E24. doi: 10.1176/appi.neuropsych.12090224. No abstract available.

PMID:
24247876
25.

Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.

Rochereau N, Drocourt D, Perouzel E, Pavot V, Redelinghuys P, Brown GD, Tiraby G, Roblin X, Verrier B, Genin C, Corthésy B, Paul S.

PLoS Biol. 2013 Sep;11(9):e1001658. doi: 10.1371/journal.pbio.1001658. Epub 2013 Sep 17.

26.

Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study.

Paul S, Del Tedesco E, Marotte H, Rinaudo-Gaujous M, Moreau A, Phelip JM, Genin C, Peyrin-Biroulet L, Roblin X.

Inflamm Bowel Dis. 2013 Nov;19(12):2568-76. doi: 10.1097/MIB.0b013e3182a77b41.

PMID:
24013361
27.

Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases.

Rinaudo-Gaujous M, Paul S, Tedesco ED, Genin C, Roblin X, Peyrin-Biroulet L.

Aliment Pharmacol Ther. 2013 Oct;38(8):914-24. doi: 10.1111/apt.12477. Epub 2013 Sep 3. Review.

28.

Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.

Roblin X, Marotte H, Rinaudo M, Del Tedesco E, Moreau A, Phelip JM, Genin C, Peyrin-Biroulet L, Paul S.

Clin Gastroenterol Hepatol. 2014 Jan;12(1):80-84.e2. doi: 10.1016/j.cgh.2013.07.010. Epub 2013 Jul 23.

PMID:
23891927
29.

Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.

Dawood R, Benjelloun F, Pin JJ, Kone A, Chanut B, Jospin F, Lucht F, Verrier B, Moog C, Genin C, Paul S.

AIDS. 2013 Mar 13;27(5):717-30. doi: 10.1097/QAD.0b013e32835cfca5.

PMID:
23719346
30.

Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.

Benjelloun F, Dawood R, Urcuqui-Inchima S, Rochereau N, Chanut B, Verrier B, Lucht F, Genin C, Paul S.

AIDS. 2013 Jul 31;27(12):1992-5.

PMID:
23696073
31.

Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties.

Pavot V, Rochereau N, Primard C, Genin C, Perouzel E, Lioux T, Paul S, Verrier B.

J Control Release. 2013 Apr 10;167(1):60-7. doi: 10.1016/j.jconrel.2013.01.015. Epub 2013 Jan 23.

PMID:
23352911
32.

Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.

Gigante M, Li G, Ferlay C, Perol D, Blanc E, Paul S, Zhao A, Tostain J, Escudier B, Negrier S, Genin C.

Anticancer Res. 2012 Dec;32(12):5447-51.

PMID:
23225450
33.

Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma.

Zhao A, Li G, Péoc'h M, Genin C, Gigante M.

Exp Mol Pathol. 2013 Feb;94(1):115-20. doi: 10.1016/j.yexmp.2012.10.005. Epub 2012 Oct 9.

PMID:
23064048
34.

Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

Benjelloun F, Lawrence P, Verrier B, Genin C, Paul S.

J Virol. 2012 Dec;86(24):13152-63. doi: 10.1128/JVI.01110-12. Epub 2012 Sep 26. Review.

35.

New insights in mucosal vaccine development.

Pavot V, Rochereau N, Genin C, Verrier B, Paul S.

Vaccine. 2012 Jan 5;30(2):142-54. doi: 10.1016/j.vaccine.2011.11.003. Epub 2011 Nov 12. Review.

PMID:
22085556
36.

Phenotypic localization of distinct DC subsets in mouse Peyer Patch.

Rochereau N, Verrier B, Pin JJ, Genin C, Paul S.

Vaccine. 2011 May 9;29(20):3655-61. doi: 10.1016/j.vaccine.2011.03.012. Epub 2011 Mar 23.

PMID:
21439318
37.

Generation of anti-DC-SIGN monoclonal antibodies capable of blocking HIV-1 gp120 binding and reactive on formalin-fixed tissue.

Canard B, Vachon H, Fontaine T, Pin JJ, Paul S, Genin C, Mueller CG.

Immunol Lett. 2011 Mar 30;135(1-2):165-72. doi: 10.1016/j.imlet.2010.11.002. Epub 2010 Nov 13.

PMID:
21078343
38.

CA9 as a molecular marker for differential diagnosis of cystic renal tumors.

Li G, Bilal I, Gentil-Perret A, Feng G, Zhao A, Peoc'h M, Genin C, Tostain J, Gigante M.

Urol Oncol. 2012 Jul-Aug;30(4):463-8. doi: 10.1016/j.urolonc.2010.04.014. Epub 2010 Sep 6.

PMID:
20822935
39.

Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells.

Primard C, Rochereau N, Luciani E, Genin C, Delair T, Paul S, Verrier B.

Biomaterials. 2010 Aug;31(23):6060-8. doi: 10.1016/j.biomaterials.2010.04.021. Epub 2010 May 14.

PMID:
20471085
40.

Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression.

Mohamed F, Vincent N, Cottier M, Peoc'h M, Merrouche Y, Patouillard B, Paul S, Genin C.

Biomarkers. 2010 Jun;15(4):315-24. doi: 10.3109/13547501003658114.

PMID:
20175704
41.

Quantification of circulating regulatory T cells by flow cytometry in kidney transplant patients after basiliximab induction therapy.

Abadja F, Alamartine E, Berthoux F, Mariat C, Genin C, Lambert C.

Transplantation. 2010 Feb 15;89(3):366-8. doi: 10.1097/TP.0b013e3181bbbd67. No abstract available.

PMID:
20145530
42.

Tissue compartment analysis for biomarker discovery by gene expression profiling.

Disset A, Cheval L, Soutourina O, Duong Van Huyen JP, Li G, Genin C, Tostain J, Loupy A, Doucet A, Rajerison R.

PLoS One. 2009 Nov 10;4(11):e7779. doi: 10.1371/journal.pone.0007779.

43.

Neutralizing inter-clade cross-reactivity of HIV-1 V1/V2-specific secretory immunoglobulin A in Colombian and French cohorts.

Granados-Gonzalez V, Piedrahita LD, Martinez-Gutierrez M, Lawrence P, Saoudin H, Zapata X, Lucht F, Pinter A, Genin C, Urcuqui-Inchima S, Riffard S.

AIDS. 2009 Oct 23;23(16):2219-22.

PMID:
19830891
44.

CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours.

Li G, Feng G, Cuilleron M, Zhao A, Gentil-Perret A, Cottier M, Genin C, Tostain J.

Histopathology. 2009 Jun;54(7):880-4. doi: 10.1111/j.1365-2559.2009.03302.x. Epub 2009 May 11.

PMID:
19469910
45.

[Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].

Granados-González V, Piedrahita LD, Martínez M, Genin C, Riffard S, Urcuqui-Inchima S.

Enferm Infecc Microbiol Clin. 2009 Nov;27(9):523-30. doi: 10.1016/j.eimc.2008.02.010. Epub 2009 May 1. Review. Spanish.

PMID:
19409660
46.

Antibodies purified from sera of HIV-1-infected patients by affinity on the heptad repeat region 1/heptad repeat region 2 complex of gp41 neutralize HIV-1 primary isolates.

Vincent N, Kone A, Chanut B, Lucht F, Genin C, Malvoisin E.

AIDS. 2008 Oct 18;22(16):2075-85. doi: 10.1097/QAD.0b013e3283101260.

PMID:
18832871
47.

Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.

Li G, Feng G, Gentil-Perret A, Genin C, Tostain J.

J Urol. 2008 Aug;180(2):510-3; discussion 513-4. doi: 10.1016/j.juro.2008.04.024. Epub 2008 Jun 11.

PMID:
18550116
48.

Elevated serum-circulating RNA in patients with conventional renal cell cancer.

Feng G, Li G, Gentil-Perret A, Tostain J, Genin C.

Anticancer Res. 2008 Jan-Feb;28(1A):321-6.

49.

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic.

Corbett M, Bogers WM, Heeney JL, Gerber S, Genin C, Didierlaurent A, Oostermeijer H, Dubbes R, Braskamp G, Lerondel S, Gomez CE, Esteban M, Wagner R, Kondova I, Mooij P, Balla-Jhagjhoorsingh S, Beenhakker N, Koopman G, van der Burg S, Kraehenbuhl JP, Le Pape A.

Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2046-51. doi: 10.1073/pnas.0705191105. Epub 2008 Feb 11.

50.

Opposite immune reactivity of serum IgG and secretory IgA to conformational recombinant proteins mimicking V1/V2 domains of three different HIV type 1 subtypes depending on glycosylation.

Granados-Gonzalez V, Claret J, Berlier W, Vincent N, Urcuqui-Inchima S, Lucht F, Defontaine C, Pinter A, Genin C, Riffard S.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):289-99. doi: 10.1089/aid.2007.0187.

PMID:
18260782

Supplemental Content

Support Center